Quick Answer
DEXCOM INC reported Operating Income Loss of $911.80 million for the year ending 2025.
- DEXCOM INC showed an increase of +52.0% in Operating Income Loss from 2024 to 2025.
- This data is from DEXCOM INC's annual report (Form 10-K), filed with the SEC on February 12, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), DEXCOM INC's Operating Income Loss has grown by 2,089.4%.
- Historical annual values: Fiscal year 2025: $911.80 million | Fiscal year 2024: $600.00 million | Fiscal year 2023: $597.70 million | Fiscal year 2022: $391.20 million | Fiscal year 2021: $265.80 million | Fiscal year 2020: $299.50 million | Fiscal year 2019: $142.30 million | Fiscal year 2018: -$186.30 million | Fiscal year 2017: -$42.50 million | Fiscal year 2016: -$63.90 million | Fiscal year 2015: -$57.10 million | Fiscal year 2014: -$21.50 million | Fiscal year 2013: -$28.90 million | Fiscal year 2012: -$55.70 million | Fiscal year 2011: -$44.80 million | Fiscal year 2010: -$45.30 million | Fiscal year 2009: -$45.83 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: